Acute generalized exanthematous pustulosis (AGEP) due to exposure to sulfuric acid and bromic acid vapor: a case report.
Acute generalized exanthematous pustulosis (AGEP, toxic pustuloderma, pustular drug eruption) is a not uncommon cutaneous reaction pattern that is usually related to drug administration. The eruption is of sudden onset and appears 7-10 days after the medication is started. A 22-year-old male patient who was a student at a chemical faculty attended our outpatient clinic with a complaint of pustular eruption on his face. According to his history, the eruption started with pruritus and erythema on his chin 3 days ago and spread to his face and chest. He explained that he had performed an experiment with sulfuric acid and bromic acid and was exposed to their vapor. His dermatological examination revealed erythema and pustules on his cheeks, on his chin, above his upper lip, and on his eyebrows. He also had a few pustules on his chest. There were no ocular, mucous membrane, or pulmonary symptoms. Histopathological examination of the skin biopsy specimen revealed superficial orthokeratosis, focal subcorneal pustule formation, and perivascular chronic inflammatory cell infiltration in superficial dermis. After administration of systemic antihistamines and wet dressing topically, we observed rapid healing of the lesions. Because there was no systemic drug intake in his history, we were concerned that exposure to sulfuric acid and bromic acid vapor caused AGEP in this patient. We present this rare case to show that the vapor of chemical materials may cause AGEP or other drug eruptions.
Bilac
Dilek Bayraktar
DB
Department of Dermatology, Medical Faculty of Celal Bayar University, Manisa, Turkey. drdilekbayraktar@yahoo.com
Ermertcan
Aylin Turel
AT
Ozturkcan
Serap
S
Sahin
M Turhan
MT
Temiz
Peyker
P
D000062:Accidents, Occupational; D000148:Acids, Noncarboxylic / Q000009:adverse effects*; D000328:Adult; D006801:Humans; D018054:Hydrobromic Acid / Q000009:adverse effects*; D007753:Laboratories; D008297:Male; D012867:Skin / Q000473:pathology; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000473:pathology; D013464:Sulfuric Acids / Q000009:adverse effects*
D000148:Acids, Noncarboxylic; D013464:Sulfuric Acids; D018054:Hydrobromic Acid; C531577:bromic acid; C033158:sulfuric acid